GlassScriptPhysician profile
Ashanda Esdaille
NPI 1982081436
$1,008.46
in general payments reported to CMS, 2019-2025
11 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.51 · 2022: $272 · 2024: $519 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $279.30 | 2024 | Urolift |
| Astellas Pharma US INC | $220.54 | 2022 | |
| Alnylam Pharmaceuticals INC. | $109.79 | 2024 | Oxlumo |
| Merck Sharp & Dohme LLC | $80.51 | 2021 | |
| Janssen Scientific Affairs, LLC | $71.14 | 2024-2025 | Erleada |
| Urogen Pharma, INC. | $71.05 | 2025 | |
| Dornier Medtech America, INC | $51.70 | 2022 | |
| Innovation Technologies INC | $36.32 | 2024 | Irrisept |
| Ferring Pharmaceuticals INC. | $35.04 | 2024 | Adstiladrin |
| Procept Biorobotics Corporation | $28.59 | 2025 | |
| Intuitive Surgical, INC. | $24.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashanda Esdaille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.